NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock Ownership - Who owns Rani Therapeutics Holdings?

Insider buying vs selling

Have Rani Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mir A. ImranDirector2025-10-232,083,334$0.61
$1.26MBuy
South Cone Investments Limited Partnership10% Owner2025-10-214,000,000$2.77
$11.07MSell
South Cone Investments Limited Partnership10% Owner2025-10-201,923,000$2.41
$4.64MSell
Kate McKinleyChief Business Officer2024-12-1317,960$1.67
$29.99kBuy
Talat ImranChief Executive Officer2024-12-0910,296$1.94
$19.97kBuy

1 of 1

RANI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RANI insiders and whales buy or sell their stock.

RANI Shareholders

What type of owners hold Rani Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mir A. Imran43.26%24,891,346$47.04MInsider
South Cone Investments Limited Partnership15.60%8,975,682$16.96MInsider
Moreno Isidoro Quiroga9.16%5,272,750$9.97MInsider
Armistice Capital LLC5.48%3,151,354$5.96MInstitution
Vanguard Group Inc1.39%799,679$1.51MInstitution
Talat Imran0.88%507,094$958.41kInsider
Nan Fung Group Holdings Ltd0.86%493,584$932.87kInstitution
Andrew Farquharson0.71%406,768$768.79kInsider
United Services Automobile Association0.53%302,743$572.18kInstitution
Mir Hashim0.47%273,265$516.47kInsider

1 of 3

RANI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RANI11.22%71.00%Net SellingNet Selling
ORMP17.68%51.57%
IFRX24.81%0.00%
DTIL13.92%86.08%Net SellingNet Buying
STTK59.88%31.06%Net BuyingNet Buying

Rani Therapeutics Holdings Stock Ownership FAQ

Who owns Rani Therapeutics Holdings?

Rani Therapeutics Holdings (NASDAQ: RANI) is owned by 11.22% institutional shareholders, 71.00% Rani Therapeutics Holdings insiders, and 17.77% retail investors. Mir A. Imran is the largest individual Rani Therapeutics Holdings shareholder, owning 24.89M shares representing 43.26% of the company. Mir A. Imran's Rani Therapeutics Holdings shares are currently valued at $41.32M.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.